Albert Bourla, CEO of Pfizer, speaks at a press conference after a visit to monitor the production of the Pfizer-BioNtech COVID-19 vaccine at the US pharmaceutical company Pfizer’s factory in Puurs, Belgium, on April 23, 2021.
John Thys | Swimming pool | Reuters
Albert Bourla, CEO of Pfizer, told CNBC on Wednesday that he believed that life could return to normal in developed countries by the end of this year and the rest of the world by the end of 2022.
By then, there should be enough Covid-19 vaccine doses for most leaders to successfully vaccinate their populations against the virus, Bourla said during an interview with Andrew Ross Sorkin at the CNBC Evolve Global Summit.
“I think the whole world will have enough volumes [of vaccine doses] vaccinate by the end of 2022 to protect everyone, “he said.” And I think the developed world will be in that situation by the end of this year. “
Pfizer and German partner BioNTech reached the milestone of producing 1 billion doses of their Covid vaccine last week, Bourla told CNBC. Companies expect to produce up to 3 million cans this year.
This is a developing story. Please check again for updates.